Publicaciones en las que colabora con PATRICIA GÁLVEZ MARTÍN (23)

2024

  1. Human mesenchymal stromal cells-laden crosslinked hyaluronic acid-alginate bioink for 3D bioprinting applications in tissue engineering

    Drug Delivery and Translational Research

2023

  1. Development and characterization of a poloxamer hydrogel composed of human mesenchymal stromal cells (hMSCs) for reepithelization of skin injuries

    International Journal of Pharmaceutics, Vol. 647

2022

  1. Progress in 3D Bioprinting Technology for Osteochondral Regeneration

    Pharmaceutics, Vol. 14, Núm. 8

  2. Tissue engineering in wound healing

    Nanotechnology and Regenerative Medicine: History, Techniques, Frontiers, and Applications (Elsevier), pp. 411-453

2021

  1. Pore geometry influences growth and cell adhesion of infrapatellar mesenchymal stem cells in biofabricated 3D thermoplastic scaffolds useful for cartilage tissue engineering

    Materials Science and Engineering C, Vol. 122

2020

  1. An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: From laboratory to patient

    Medicinal Research Reviews, Vol. 40, Núm. 4, pp. 1315-1334

  2. Anti-inflammatory nanomedicines: What does the future hold?

    Nanomedicine, Vol. 15, Núm. 14, pp. 1357-1360

2019

  1. Design and evaluation of mesenchymal stem cells seeded chitosan/glycosaminoglycans quaternary hydrogel scaffolds for wound healing applications

    International Journal of Pharmaceutics, Vol. 570

  2. Principal criteria for evaluating the quality, safety and efficacy of hMSC-based products in clinical practice: Current approaches and challenges

    Pharmaceutics, Vol. 11, Núm. 11

2018

  1. Clinical application of cell, gene and tissue therapies in Spain

    Revista Clinica Espanola

  2. Main analytical methods for the viability assessment of mesenchymal stem cells for use as cellular medicines

    Current Pharmaceutical Analysis, Vol. 14, Núm. 5, pp. 427-436

2017

  1. Encapsulation in cell therapy: Methodologies, materials, and clinical applications

    Current Pharmaceutical Biotechnology, Vol. 18, Núm. 5, pp. 365-377

2016

  1. Mesenchymal Stem Cells as Therapeutics Agents: Quality and Environmental Regulatory Aspects

    Stem Cells International, Vol. 2016

2015

  1. Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery

    Carbohydrate Polymers, Vol. 117, pp. 140-149

2014

  1. Desarrollo, caracterización y estudio de estabilidad de un medicamento celular para el tratamiento de la isquemia crítica de miembros inferiores en pacientes diabéticos tipo ii

    Desarrollo, caracterización y estudio de estabilidad de un medicamento celular para el tratamiento de la isquemia crítica de miembros inferiores en pacientes diabéticos tipo ii

  2. Enhancing effect of glucose microspheres in the viability of human mesenchymal stem cell suspensions for clinical administration

    Pharmaceutical Research, Vol. 31, Núm. 12, pp. 3515-3528

  3. Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use

    Stem Cells and Development, Vol. 23, Núm. 10, pp. 1074-1083

  4. Study of the stability of packaging and storage conditions of human mesenchymal stem cell for intra-arterial clinical application in patient with critical limb ischemia

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 86, Núm. 3, pp. 459-468

2013

  1. Development of a cell-based medicinal product: Regulatory structures in the European Union

    British Medical Bulletin, Vol. 105, Núm. 1, pp. 85-105

2011

  1. Elaboration, characterization, and stability study of a sunscreen emulsion for use as a towelette application in pediatric photoprotection

    Journal of Cosmetic Science, Vol. 62, Núm. 4, pp. 371-382